GABRB3 and prostate carcinoma: To understand the clinical implications of GABRB3 in prostate cancer, we conducted a pooled analysis of GABRB3 expression levels between prostate cancer and the corresponding normal tissues by employing 16 publicly accessible prostate cancer gene expression datasets with 1237 prostate cancer samples and 289 normal prostate tissues.